Abstract
Early knowledge on the structures of metabolites from in vitro and in vivo metabolism studies is very useful for improving the biopharmaceutical, efficacy and safety properties of lead candidates in drug discovery. The recognition of the value in what metabolite identification brings to drug discovery led to its inclusion in ADMET toolbox and recent trend to multiplex assessment of metabolic stability and metabolite identification. In this chapter, we will cover the in vitro and in vivo systems typically used for metabolite identification. Fast LC-MS/MS with capability of data-dependent multiple-stage mass analysis is the instrument of choice and the workhorse for multiplexing assessment of metabolic stability and metabolite identification from a single analysis. Therefore, various LC-MS/MS instruments and techniques used for metabolite identification including software to speed up data-mining along with estimating major metabolites based on UV methods will be discussed. In general, the exact site of biotransformation is difficult to obtain based solely on MS data. As a result, microchemistry will also be discussed to help narrowing down site of modification in metabolites.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Cheng KC, Korfmacher WA, White RE, Njoroge FG (2007) Lead optimization in discovery drug metabolism and pharmacokinetics/case study: the hepatitis C virus (HCV) protease inhibitor SCH 503034. Perspect Medicin Chem 1:1–9
Kalgutkar AS, Dalvie D, Obach RS, Smith DA (2012) Role of reactive metabolites in drug-induced toxicity—the tale of acetaminophen, halothane, hydralazine, and tienilic acid. In: Reactive drug metabolites. Eds. Mannhold R, Kubinyi H, and Folkers G. Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Zhang Z, Zhu M, Tang W (2009) Metabolite identification and profiling in drug design: current practice and future directions. Curr Pharm Des 15:2220–2235
Working with hepatocytes in suspension (Video tutorials included 1) Thawing cryosuspension hepatocytes; 2) Cell counting using the Trypan Blue exclusion method and 3) Reconstitution of cryosuspension hepatocytes. http://www.celsisivt.com/working-with-hepatocytes-in-suspension from Celsis/In Vitro Technology
Yan Z, Caldwell GW, Maher N (2008) Unbiased high-throughput screening of reactive metabolites on the linear ion trap mass spectrometer using polarity switch and mass tag triggered data-dependent acquisition. Anal Chem 80:6410–6422
Mutlib A, Lam W, Atherton J, Chen H, Galatsis P, Stolle W (2005) Application of stable isotope labeled glutathione and rapid scanning mass spectrometers in detecting and characterizing reactive metabolites. Rapid Commun Mass Spectrom 19:3482–3492
Bonn B, Leandersson C, Fontaine F, Zamora I (2010) Enhanced metabolite identification with MS(E) and a semi-automated software for structural elucidation. Rapid Commun Mass Spectrom 24:3127–3138
Ruijken MMA (2010) MsXelerator RM: a software platform for reactive metabolite detection using low and high resolution mass spectrometry data. The 58th American Society for Mass Spectrometry (ASMS). Salt Lake City, UT, 23–27 May
Actis-Goretta L, Lévèques A, Giuffrida F, Destaillats F, Nagy K (2012) Identification of O-methyl-(−)-epicatechin-O-sulphate metabolites by mass-spectrometry after O-methylation with trimethylsilyldiazomethane. J Chromatogr A 1245:150–157
Nagy K, Redeuil K, Williamson G, Rezzi S, Dionisi F, Longet K, Destaillats F, Renouf M (2011) First identification of dimethoxycinnamic acids in human plasma after coffee intake by liquid chromatography-mass spectrometry. J Chromatogr A 1218(2011):491
Lamoureux G, Aguero C (2009) A comparison of several modern alkylating agents. ARKIVOC i:251–264
Kulanthaivel P, Barbuch RJ, Davidson RS, Yi P, Rener GA, Mattiuz EL, Hadden CE, Goodwin LA, Ehlhardt WJ (2004) Selective reduction of N-oxides to amines: application to drug metabolism. Drug Metab Dispos 32:966–972
Chen G, Daaro I, Pramanik BN, Piwinski JJ (2009) Structural characterization of in vitro rat liver microsomal metabolites of antihistamine desloratadine using LTQ-Orbitrap hybrid mass spectrometer in combination with online hydrogen/deuterium exchange HR-LC/MS. J Mass Spectrom 44:203–213
Lam W, Ramanathan R (2002) In electrospray ionization source hydrogen/deuterium exchange LC–MS and LC–MS/MS for characterization of metabolites. J Am Soc Mass Spectrom 13:345–353
Tolonen A, Turpeinen M, Uusitalo J, Pelkonen O (2005) A simple method for differentiation of monoisotopic drug metabolites with hydrogen–deuterium exchange liquid chromatography/electrospray mass spectrometry. Eur J Pharm Sci 25:155–162
Peiris DM, Lam W, Michael S, Ramanathan R (2004) Distinguishing N-oxide and hydroxyl compounds: impact of heated capillary/heated ion transfer tube in inducing atmospheric pressure ionization source decompositions. J Mass Spectrom 39:600–606
Wang WW, Khetani SR, Krzyzewski S, David Duignan D, Obach RS (2010) Assessment of micropatterned hepatocyte co-culture system to generate metabolites. Drug Metab Dispos 38:1900–1905
Josephs JL, Sanders M (2005) Chapter 13: an integrated LC-MS strategy for preclinical candidate optimization. In: Lee MS (ed) Integrated strategies for drug discovery using mass spectrometry. Wiley, New York, p 379
Yang Y, Grubb MF, Luk CE, Humphreys WG, Josephs JL (2011) Quantitative estimation of circulating metabolites without synthetic standards by ultra-high-performance liquid chromatography/high resolution accurate mass spectrometry in combination with UV correction. Rapid Commun Mass Spectrom 25:3245–3251
Sanders M, Ruzicka J, McHale K, Shipkova P. Thermo application notes # 476: accurate and sensitive all-ions quantitation using ultra-high resolution LC/MS http://planetorbitrap.com/data/uploads/ZFS1327867271789_AN476.pdf
Baillie TA, Davis MR (1993) Mass spectrometry in the analysis of glutathione conjugates. Biol Mass Spectrom 22:319–325
Lafaye A, Junot C, Gall BR, Fritsch P, Ezan E, Tabet J-C (2004) Profiling of sulfoconjugates in urine using precursor ion and neutral loss scans in tandem mass spectrometry. Application to the investigation of heavy metal toxicity in rats. J Mass Spectrom 39:655–664
Xia Y-Q, Miller JD, Bakhtiar R, Franklin RB, Liu DQ (2003) Use of a quadrupole linear ion trap mass spectrometer in metabolite identification and bioanalysis. Rapid Commun Mass Spectrom 17:1137–1145
Liu DQ, Hop CECA (2005) Strategies for characterization of drug metabolites using liquid chromatography-tandem mass spectrometry in conjunction with chemical derivatization and on-line H/D exchange approaches. J Pharm Biomed Anal 37:1–18
Jackson PJ, Brownsill RD, Taylor AR, Walther B (1995) Use of electrospray ionization and neutral loss liquid chromatography/tandem mass spectrometry in drug metabolism studies. J Mass Spectrom 30:446–451
Clarke NJ, Rindgen D, Korfmacher WA, Cox KA (2001) Systematic LC/MS metabolite identification in drug discovery. Anal Chem 73:430A–439A
Kostiainen R, Kotiaho T, Kuuranne T, Auriola S (2003) Liquid chromatography/atmospheric pressure ionization-mass spectrometry in drug metabolism studies. J Mass Spectrom 38:357–372
Zhang H, Zhang D, Ray K (2003) A software filter to remove interference ions from drug metabolites in accurate mass liquid chromatography/mass spectrometric analyses. J Mass Spectrom 38:1110–1112
Zhang H, Zhang D, Ray K, Zhu M (2009) Mass defect filter technique and its applications to drug metabolite identification by high-resolution mass spectrometry. J Mass Spectrom 44:999–1016
Zhu M, Zhang H, Yao M, Zhang D, Ray K, Skiles GL (2004) Detection of metabolites in plasma and urine using a high resolution LC/MS-based mass defect filter approach: comparison with precursor ion and neutral loss scan analyses. Drug Metab Rev 36(Suppl 1):43
Mortishire-Smith RJ, O’Connor D, Castro-Perez JM, Kirby J (2005) Accelerated throughput metabolic route screening in early drug discovery using high-resolution liquid chromatography/quadrupole time-of-flight mass spectrometry and automated data analysis. Rapid Commun Mass Spectrom 19:2659–2670
Lim HK, Chen J, Cook K, Sensenhauser C, Silva J, Evans DC (2008) A generic method to detect electrophilic intermediates using isotopic pattern triggered data-dependent high-resolution accurate mass spectrometry. Rapid Commun Mass Spectrom 22:1295–1311
Cuyckens F, Hurkmans R, Castro-Perez JM, Leclercq L, Mortishire-Smith RJ (2009) Extracting metabolite ions out of a matrix background by combined mass defect, neutral loss and isotope filtration. Rapid Commun Mass Spectrom 23:327–332
Acknowledgements
The views expressed here are solely those of the author and do not reflect the opinions of Janssen Research & Development, LLC.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this protocol
Cite this protocol
Lam, W.W., Chen, J., Xu, R.F., Silva, J., Lim, HK. (2014). Metabolite Identification in Drug Discovery. In: Caldwell, G., Yan, Z. (eds) Optimization in Drug Discovery. Methods in Pharmacology and Toxicology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-742-6_26
Download citation
DOI: https://doi.org/10.1007/978-1-62703-742-6_26
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-62703-741-9
Online ISBN: 978-1-62703-742-6
eBook Packages: Springer Protocols